These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27516318)

  • 1. Enhanced inhibition of bacterial biofilm formation and reduced leukocyte toxicity by chloramphenicol:β-cyclodextrin:N-acetylcysteine complex.
    Aiassa V; Zoppi A; Becerra MC; Albesa I; Longhi MR
    Carbohydr Polym; 2016 Nov; 152():672-678. PubMed ID: 27516318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production.
    Aiassa V; Zoppi A; Albesa I; Longhi MR
    Carbohydr Polym; 2015 May; 121():320-7. PubMed ID: 25659705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation.
    Dan Córdoba AV; Aiassa V; Longhi MR; Quevedo MA; Zoppi A
    AAPS PharmSciTech; 2020 Jun; 21(5):163. PubMed ID: 32488738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous improvement of ketoconazole solubility, antifungal and antibiofilm activity by multicomponent complexation.
    Zoppi A; Bartolilla A; Longhi MR; Aiassa V
    Ther Deliv; 2020 Nov; 11(11):701-712. PubMed ID: 32967581
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity.
    Jaiswal S; Bhattacharya K; McHale P; Duffy B
    J Mater Sci Mater Med; 2015 Jan; 26(1):5367. PubMed ID: 25596861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Chloramphenicol/Amino Acid Combinations Exhibiting Enhanced Dissolution Rates and Reduced Drug-Induced Oxidative Stress.
    Sterren VB; Aiassa V; Garnero C; Linck YG; Chattah AK; Monti GA; Longhi MR; Zoppi A
    AAPS PharmSciTech; 2017 Nov; 18(8):2910-2918. PubMed ID: 28429292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: phase solubility and spectroscopic methods.
    Shi JH; Zhou YF
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 83(1):570-4. PubMed ID: 21945123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical [corrected] properties of the inclusion complex of puerarin and glucosyl-β-cyclodextrin.
    Liu B; Zhao J; Liu Y; Zhu X; Zeng J
    J Agric Food Chem; 2012 Dec; 60(51):12501-7. PubMed ID: 23215052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
    Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
    Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells.
    Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M
    J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.